Who Owns BBH?

VanEck Biotech ETF — Institutional Ownership & 13F Holdings

$185.45

+1.30 (+0.71%)

Market Cap

$399.7M

Shares Outstanding

2,001,361

Institutional Holders

99

Total Inst. Value

$122.8M

% of Float Held

QoQ Holder Change

+14

Institutional data as of Q1 2025

New Positions

15

Closed Positions

19

Increased

14

Decreased

36

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1GOLDMAN SACHS GROUP INC$16.7M106,181
2Miller Investment Management, LP$14.4M91,805
3MORGAN STANLEY$12.1M76,972
4TD Waterhouse Canada Inc.$10.0M64,708
5WELLS FARGO & COMPANY/MN$9.7M61,908
6JONES FINANCIAL COMPANIES LLLP$9.5M152,070
7BANK OF AMERICA CORP /DE/$7.0M44,568
8UBS Group AG$4.4M27,859
9NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO$3.5M22,361
10RAYMOND JAMES FINANCIAL INC$3.1M19,643

Biggest Buyers & Sellers This Quarter

Related Stocks

Frequently Asked Questions

How many institutional investors hold BBH?

As of Q1 2025, 99 institutional investors report holding BBH (VanEck Biotech ETF) in their 13F filings.

Which hedge fund owns the most BBH?

The largest institutional holder of BBH is GOLDMAN SACHS GROUP INC with $16.7M in shares.

Are institutions buying or selling BBH?

This quarter, 15 institutions opened new positions in BBH and 19 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.